Literature DB >> 17072916

In-hospital use of opioids increases rate of coded postoperative paralytic ileus.

Wim G Goettsch1, Myrthe P P Sukel, Donald L van der Peet, Melanie M van Riemsdijk, Ron M C Herings.   

Abstract

PURPOSE: To determine the association between opioid use and the occurrence of postoperative paralytic ileus (POI) after different types of surgery.
METHODS: The PHARMO database was used to perform a case control study in which intramural drug utilisation data were linked to hospital discharge diagnoses. All patients admitted for digestive, abdominal or genito-urinary surgeries were selected in 1998-2003. Cases with coded POI (ICD-9-CM 560.1 and 564.4) and controls with no POI were matched 1:10. The association between coded POI and opioid use was assessed using conditional logistic regression.
RESULTS: In 0.2% of all admissions (total of 180,279), patients developed POI and in 18% of all admissions, patients received opioids. Three hundred and sixty-six cases with POI were selected with their matching controls. The use of (nico)morphine was associated with the risk for developing POI (odds ratio (OR) 12.1, 95% confidence interval (CI) 5.4-27.1). The association between opioids and POI was most obvious in patients with abdominal surgery (OR 33.8, 95% CI 6.2-184.6) and patients without colon/colorectal/rectal tumours (OR 13.2, 95%CI 5.7-30.3).
CONCLUSION: This study demonstrated a distinct association between the use of opioids, in particular natural opium alkaloids, and the risk for coded POI. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17072916     DOI: 10.1002/pds.1338

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  17 in total

Review 1.  Reducing the burden of postoperative ileus: evaluating and implementing an evidence-based strategy.

Authors:  Jeffrey F Barletta; Anthony J Senagore
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

2.  Risk factors for prolonged postoperative ileus after laparoscopic sphincter-saving total mesorectal excision for rectal cancer: an analysis of 428 consecutive patients.

Authors:  Elisabeth Hain; Léon Maggiori; Cécile Mongin; Justine Prost A la Denise; Yves Panis
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

3.  Risk factors for prolonged postoperative ileus after colorectal cancer surgery.

Authors:  Monica Millan; Sebastiano Biondo; Domenico Fraccalvieri; Ricardo Frago; Thomas Golda; Esther Kreisler
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 4.  Postoperative pain control.

Authors:  Veerabhadram Garimella; Christina Cellini
Journal:  Clin Colon Rectal Surg       Date:  2013-09

Review 5.  Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review.

Authors:  Paramita Basu; Camelia Maier; Arpita Basu
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

6.  An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liPosome foRmulation Of bupiVacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal.

Authors:  Jorge E Marcet; Valentine N Nfonsam; Sergio Larach
Journal:  J Pain Res       Date:  2013-07-18       Impact factor: 3.133

7.  Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure.

Authors:  Frank J Defalco; Patrick B Ryan; M Soledad Cepeda
Journal:  Health Serv Outcomes Res Methodol       Date:  2012-10-27

8.  Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial.

Authors:  Jon D Vogel
Journal:  J Pain Res       Date:  2013-07-29       Impact factor: 3.133

9.  Retrospective analysis of quality improvement when using liposome bupivacaine for postoperative pain control.

Authors:  Nicole M King; Albin S Quiko; James G Slotto; Nicholas C Connolly; Robert J Hackworth; Justin W Heil
Journal:  J Pain Res       Date:  2016-04-21       Impact factor: 3.133

10.  Transversus abdominis plane block with liposomal bupivacaine compared to oral opioids alone for acute postoperative pain after laparoscopic hysterectomy for early endometrial cancer: a cost-effectiveness analysis.

Authors:  Brandon-Luke L Seagle; Emily S Miller; Anna E Strohl; Anna Hoekstra; Shohreh Shahabi
Journal:  Gynecol Oncol Res Pract       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.